Tiziana Life Sciences announces that it has been notified that Gabriele Cerrone, its Chairman and Acting CEO, purchased 7,500 common shares at $0.79 per share, bringing his total holding to 38,693,237 common shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on TLSA:
- Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO
- Tiziana Life Sciences announces purchase of common shares by chairman
- Tiziana Life Sciences Highlighted in Forbes Article
- Tiziana Life Sciences announces FORBES article highlighting foralumab
- Tiziana Life Sciences announces publication in PNAS on foralumab